[PDF][PDF] An open‐label, dose‐escalation study to assess the safety and efficacy of IL‐22 agonist F‐652 in patients with alcohol‐associated hepatitis
Background and Aims Interleukin‐22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol‐associated hepatitis (AH). F‐652 is a …
hepatic regeneration that characterize alcohol‐associated hepatitis (AH). F‐652 is a …
An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
JP Arab, TS Sehrawat, DA Simonetto… - Hepatology …, 2020 - pubmed.ncbi.nlm.nih.gov
Background and aims Interleukin-22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …
hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …
An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
JP Arab, TS Sehrawat, DA Simonetto… - …, 2020 - mayoclinic.elsevierpure.com
Abstract Background and Aims: Interleukin-22 has beneficial effects on inflammation and
impaired hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …
impaired hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …
An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.
JP Arab, TS Sehrawat, DA Simonetto… - Hepatology …, 2020 - europepmc.org
Conclusions F-652 is safe in doses up to 45 μg/kg and associated with a high rate of
improvement as determined by Lille and MELD scores, reductions in markers of …
improvement as determined by Lille and MELD scores, reductions in markers of …
[HTML][HTML] AN OPEN LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF IL-22 AGONIST F-652 IN PATIENTS WITH ALCOHOLIC …
JP Arab, TS Sehrawat, DA Simonetto… - Hepatology …, 2020 - ncbi.nlm.nih.gov
Background: Interleukin-22 (IL-22) has beneficial effects on inflammation and impaired
hepatic regeneration, that characterize AH. F-652 is a recombinant fusion protein of human …
hepatic regeneration, that characterize AH. F-652 is a recombinant fusion protein of human …
An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis
JP Arab, TS Sehrawat, DA Simonetto, VK Verma… - Hepatology, 2020 - journals.lww.com
Conclusions F‐652 is safe in doses up to 45 μg/kg and associated with a high rate of
improvement as determined by Lille and MELD scores, reductions in markers of …
improvement as determined by Lille and MELD scores, reductions in markers of …
[PDF][PDF] An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
JP Arab, TS Sehrawat, DA Simonetto, VK Verma… - 2020 - scholarworks.iupui.edu
Background and aims: Interleukin-22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …
hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …
[引用][C] An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
JP Arab, TS Sehrawat, DA Simonetto… - Hepatology (Baltimore …, 2020 - elibrary.ru
[PDF][PDF] AN OPEN LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF IL-22 AGONIST F-652 IN PATIENTS WITH ALCOHOLIC …
JP Arab, TS Sehrawat, DA Simonetto… - …, 2020 - scholarworks.iupui.edu
AN OPEN LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF
IL-22 AGONIST F-652 IN PATIENTS WITH ALCOHOLIC HEPATIT Page 1 AN OPEN LABEL …
IL-22 AGONIST F-652 IN PATIENTS WITH ALCOHOLIC HEPATIT Page 1 AN OPEN LABEL …